Cargando…

Acute atomoxetine treatment of younger and older children with ADHD: A meta-analysis of tolerability and efficacy

BACKGROUND: Atomoxetine is FDA-approved as a treatment of attention-deficit/hyperactivity disorder (ADHD) in patients aged 6 years to adult. Among pediatric clinical trials of atomoxetine to date, six with a randomized, double-blind, placebo-controlled design were used in this meta-analysis. The pur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kratochvil, Christopher J, Milton, Denái R, Vaughan, Brigette S, Greenhill, Laurence L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556311/ https://www.ncbi.nlm.nih.gov/pubmed/18793405 http://dx.doi.org/10.1186/1753-2000-2-25

Ejemplares similares

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015)

Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006)

The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
por: Fu, Di, et al.
Publicado: (2022)

Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
por: Houghton, Richard, et al.
Publicado: (2019)

Social and emotional difficulties in children with ADHD and the impact on school attendance and healthcare utilization
por: Classi, Peter, et al.
Publicado: (2012)

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
por: Treuer, Tamás, et al.
Publicado: (2016)

Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: A fNIRS study
por: Nagashima, Masako, et al.
Publicado: (2014)

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
por: Dittmann, Ralf W, et al.
Publicado: (2009)

Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)

Atomoxetine as an Alternative Therapy for Adolescent Adhd With Comorbid Cerebral Palsy: A Case Report
por: Calilung, Dominique, et al.
Publicado: (2023)

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
por: Hennissen, Leonie, et al.
Publicado: (2017)

Treatment of Children and Adolescents with Epilepsy with Atomoxetine
por: Park, Kee Jeong, et al.
Publicado: (2020)

Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Kohn, Michael R., et al.
Publicado: (2012)

Shared and Drug-Specific Effects of Atomoxetine and Methylphenidate on Inhibitory Brain Dysfunction in Medication-Naive ADHD Boys
por: Cubillo, Ana, et al.
Publicado: (2014)

Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD
por: Kowalczyk, Olivia S., et al.
Publicado: (2023)

P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
Publicado: (2020)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
por: Byun, Jung‐Ick, et al.
Publicado: (2019)

Influence of Atomoxetine on Relationship Between ADHD Symptoms and Prefrontal Cortex Activity During Task Execution in Adult Patients
por: Sugimoto, Atsunori, et al.
Publicado: (2021)

Factors Associated With Initiation With Atomoxetine Versus Stimulants in the Treatment of Adults With ADHD: Retrospective Analysis of Administrative Claims Data
por: Van Brunt, David L., et al.
Publicado: (2006)

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
por: Hanwella, Raveen, et al.
Publicado: (2011)

Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis
por: Rezaei, Golandam, et al.
Publicado: (2016)

The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression
por: Liang, Edwin F., et al.
Publicado: (2018)

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?
por: Fairman, Kathleen A., et al.
Publicado: (2018)

Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring
por: Zito, Julie M, et al.
Publicado: (2008)

The effect of atomoxetine on random and directed exploration in humans
por: Warren, Christopher M., et al.
Publicado: (2017)

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
por: Wehmeier, Peter M, et al.
Publicado: (2010)

Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study
por: Adler, Lenard A., et al.
Publicado: (2014)

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
por: Nagai, Tsutomu, et al.
Publicado: (2022)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
por: Clemow, David B, et al.
Publicado: (2017)

Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
por: Fenderson, Joshua L., et al.
Publicado: (2013)

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies
por: Wehmeier, Peter M, et al.
Publicado: (2009)

Barnidipine Real-Life Efficacy and Tolerability in Arterial Hypertension: Results from Younger and Older Patients in the BASIC-HT Study
por: Lins, Robert, et al.
Publicado: (2017)

Cognitive flexibility in younger and older children who stutter
por: Paphiti, Maria, et al.
Publicado: (2022)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Hammerness, Paul, et al.
Publicado: (2009)

Targeting impulsivity in Parkinson’s disease using atomoxetine
por: Kehagia, Angie A., et al.
Publicado: (2014)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015)

Off-label use of atomoxetine in adults: is it safe?
por: Dadashova, Rana, et al.
Publicado: (2012)

Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
por: Ye, Zheng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_39ntc8s6novokr1jrrfodpjtf7